SCHEMBL19967170

SCHEMBL19967170

CCc1cc(C)c(-c2c(C)nn(C)c2-c2ccc(Cl)cc2)c(F)c1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 3/20 0.41
CRHR1 P34998 3/20 0.39
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.37
HPGD P15428 1/20 0.37
PGR P06401 2/20 0.36
NR3C2 P08235 2/20 0.36
MAPT P10636 3/20 0.35
NR1H2 P55055 1/20 0.34
NR1H3 Q13133 1/20 0.34
SLC34A1 Q06495 1/20 0.34
HTT P42858 1/20 0.33
BACE1 P56817 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
GRM5 P41594 1/20 0.33
CNR2 P34972 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19967295 0.77 KMT2A (0.34) CRHR1KDM4EHPGDPGRNR3C2
SCHEMBL12871872 0.70 CRHR1 (0.46) PDE2ACRHR1ALDH1A1NR1H2NR1H3
SCHEMBL1025606 0.69 GRM5 (0.38) PDE2ACRHR1MAPTNR1H2NR1H3
SCHEMBL5254957 0.68 PDE2A (0.49) PDE2ACRHR1ALDH1A1KDM4EHPGD
SCHEMBL14996603 0.67 CNR1 (0.48) PDE2ACRHR1ALDH1A1KDM4EHPGD
SCHEMBL27519517 0.65 PDE2A (0.46) PDE2AALDH1A1KDM4EMAPTNR1H2
SCHEMBL1023884 0.65 CYP1A2 (0.38) PDE2ACRHR1KDM4EMAPTBACE1
SCHEMBL14010474 0.65 RAB9A (0.36) ALDH1A1MAPTHTTMEN1KMT2A
SCHEMBL3489183 0.64 SMN1; SMN2 (0.48) PDE2ACRHR1ALDH1A1KDM4EHPGD
SCHEMBL19953206 0.63 POLB (0.38) MAPTHTTBACE1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018048969-A1 MULTI-TARGETED HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2018-03-15 WO disclosed